
Raagbp Pharmaceuticals Private Limited
Provides healthcare services through a registered office in Delhi since 2019.
Provides healthcare services through a registered office in Delhi since 2019.
Raagbp Pharmaceuticals Private Limited (RPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 01 October 2019 (Five years and five months 0 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.02 M.
The company currently has active open charges totaling ₹4.18 Cr. The company has closed loans amounting to ₹3.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rama Goyal and Avinash Goyal serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
-
U24230DL2019PTC355706
355706
Private Limited Indian Non-Government Company
01 Oct 2019
27 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rama Goyal ![]() | Director | 01-Oct-2019 | Current |
Avinash Goyal ![]() | Director | 01-Oct-2019 | Current |
Raagbp Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 369.33% increase. The company also saw a substantial improvement in profitability, with a 2421.09% increase in profit. The company's net worth Soared by an impressive increase of 287.2%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Raagbp Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹41.80 M
₹38.50 M
Date | Lender | Amount | Status |
---|---|---|---|
16 Jul 2024 | Axis Bank Limited | ₹4.18 Cr | Open |
17 Nov 2022 | Canara Bank | ₹3.85 Cr | Satisfied |
Unlock and access historical data on people associated with Raagbp Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Raagbp Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raagbp Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Raagbp Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
27 Sep 2024
A charge with Axis Bank Limited amounted to Rs. 41.80 M with Charge ID 100977060 was registered on 16 Jul 2024.
16 Jul 2024
Raagbp Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
31 Mar 2024
A charge registered on 17 Nov 2022 via Charge ID 100684198 with Canara Bank was fully satisfied on 30 Nov 2023.
30 Nov 2023
A charge with Canara Bank amounted to Rs. 38.50 M with Charge ID 100684198 was registered on 17 Nov 2022.
17 Nov 2022
Rama Kant Goyal was appointed as a Director was appointed as a Director on 01 Oct 2019 & has been associated with this company since 5 years 5 months .
01 Oct 2019
Raagbp Pharmaceuticals Private Limited was incorporated on 01 Oct 2019.
The authorized share capital of Raagbp Pharmaceuticals Private Limited is ₹ 3.00 M and paid-up capital is ₹ 1.02 M.
Currently 2 directors are associated with Raagbp Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Raagbp Pharmaceuticals Private Limited is H No.2027-B Pvt-2027/156 Plot No Old-124 -125 Kh.No 243 Ground Floor Ganeshpura-B India, Delhi, 110035.
The corporate identification number (CIN) of Raagbp Pharmaceuticals Private Limited is U24230DL2019PTC355706 and the company number is 355706 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Raagbp Pharmaceuticals Private Limited has risen by 369.33%.
The financial reports for the fiscal year 2022 indicates that The net worth of Raagbp Pharmaceuticals Private Limited has experienced an upsurge of 287.20%.
As per the financial statements for fiscal Year 2022, The total open charges for Raagbp Pharmaceuticals Private Limited amount to ₹ 4.18 Cr.
The most recent Balance Sheet for Raagbp Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.